Escitalopram Oxalate Pharmaceutical API
Pharmaceutical Premium
Pharmaceutical API

Escitalopram Oxalate

High-purity pharmaceutical grade Escitalopram Oxalate API manufactured to meet stringent USP/EP specifications for antidepressant medication production. Our pharmaceutical-grade Escitalopram Oxalate delivers exceptional quality and consistency for critical pharmaceutical applications.

  • USP/EP Compliant Grade
  • High Purity (>99.5%)
  • SSRI Antidepressant API
  • GMP Certified Manufacturing
  • Reliable Supply Chain
  • Complete Documentation
Request Quote Technical Support

Technical Specifications

Chemical Formula: C20H21FN2O·(COOH)2
CAS Number: 219861-08-2
Molecular Weight: 414.40 g/mol
Purity (HPLC): ≥99.5% (pharmaceutical grade)
Physical State: White to off-white crystalline powder
Water Content (Karl Fischer): ≤0.5%
Residue on Ignition: ≤0.1%
Heavy Metals (as Pb): ≤10 ppm
Related Substances: ≤0.5% total impurities
Storage Conditions: Store in cool, dry place (15-30°C)
Packaging Options: 1kg, 5kg pharmaceutical containers

Applications

Antidepressant Drug Manufacturing
SSRI Formulations
Oral Pharmaceutical Products
API Synthesis & Development
Depression Treatment Research
Pharmaceutical Research
Drug Product Manufacturing
Quality Control Testing
Regulatory Compliance
Clinical Trial Materials
Bioanalytical Method Development
Reference Standard Applications

Industry-Specific Grades

DRAVYOM offers specialized Escitalopram Oxalate grades tailored for specific pharmaceutical requirements, ensuring optimal performance and regulatory compliance across diverse antidepressant drug manufacturing applications.

USP Grade (Pharmaceutical)
Purity: ≥99.5% (HPLC) Water Content: ≤0.5% Heavy Metals: ≤10 ppm Application: Pharmaceutical formulations
EP Grade (European Pharmacopoeia)
Purity: ≥99.5% (pharmaceutical) Related Substances: ≤0.5% Residue on Ignition: ≤0.1% Application: European market compliance
Research Grade
Purity: ≥98.0% (analytical) Water Content: ≤1.0% Particle Size: Controlled Application: R&D, method development
GMP Grade
Purity: ≥99.8% (pharmaceutical) Endotoxins: ≤2.5 EU/mg Microbial Limits: Compliant Application: CNS disorder formulations

Quality Standards

DRAVYOM's pharmaceutical grade Escitalopram Oxalate is manufactured under stringent cGMP protocols, meeting international pharmaceutical standards including USP, EP, and ICH guidelines. Our pharmaceutical-grade production ensures consistent quality and regulatory compliance.

cGMP Certified Manufacturing
USP/EP Grade Specifications
≥99.5% Pharmaceutical Purity
Advanced Analytical Testing
Comprehensive Impurity Control
Batch-to-Batch Consistency
Complete Documentation Package
Temperature-Controlled Logistics

Advanced Chemical Properties & Performance

Pharmaceutical grade Escitalopram Oxalate exhibits exceptional chemical properties essential for CNS therapy applications. Its ultra-pure composition and precise molecular structure ensure reliable performance in demanding pharmaceutical formulations and research applications.

Analytical Properties
Solubility (Water): Freely soluble
LogP (octanol/water): 3.5
pKa: 9.9
Molecular Weight: 414.43 g/mol
Physical Properties
Appearance: White to off-white crystalline powder
Melting Point: 152-154°C
Bulk Density: 0.5-0.7 g/mL
Hygroscopicity: Hygroscopic
Pharmaceutical Performance
Bioavailability: 80% (oral)
Protein Binding: 56%
Half-life: 27-32 hours
Mechanism: Selective serotonin reuptake inhibitor
Purity Specifications
Assay (HPLC): ≥99.5%
Related Substances: ≤0.5% total
Water Content: ≤0.5% (Karl Fischer)
Residue on Ignition: ≤0.1%
Stability Properties
Shelf Life: 3 years (unopened)
Light Sensitivity: Protect from light
Temperature Stability: Store below 25°C
pH Stability: Stable in neutral conditions

Performance Characteristics

Detailed performance metrics demonstrate pharmaceutical grade Escitalopram Oxalate superiority in CNS applications with exceptional selective serotonin reuptake inhibition, antidepressant efficacy, and reproducibility across diverse therapeutic protocols.

Selective SSRI

Highly selective serotonin reuptake inhibition

Superior selectivity profile
Antidepressant Efficacy

Proven antidepressant and anxiolytic activity

Dual therapeutic benefits
Stability Profile

Chemical stability: Excellent under storage conditions

Maintains potency for 3 years
Thermal Stability

Melting point: 152-154°C

Stable during pharmaceutical processing
Batch Reproducibility

Variation: ±0.1% between batches

Consistent therapeutic efficacy
Long Half-life

27-32 hour half-life for once-daily dosing

Convenient dosing schedule

Safety Information

Prescription pharmaceutical ingredient requiring professional handling. Well-established safety profile for CNS therapy. Handle with pharmaceutical-grade safety precautions and ensure proper GMP environmental controls. Clinical monitoring for serotonin syndrome and withdrawal symptoms during therapeutic use.

Prescription Only
Professional Use
Monitor for serotonin syndrome

Storage & Handling

Store in original containers in a cool, dry, well-ventilated area away from moisture and light. Keep containers tightly closed and maintain pharmaceutical-grade environmental controls. Use appropriate GMP handling techniques for API processing.

Cool storage (15-25°C)
Protect from moisture (hygroscopic)
Protect from light
GMP handling required

Chemical Mechanisms & Reaction Pathways

Escitalopram Oxalate exhibits selective serotonin reuptake inhibition properties through high-affinity binding to serotonin transporter proteins, increasing synaptic serotonin availability for enhanced mood regulation and anxiety reduction.

SSRI Mechanism

Selective inhibition of serotonin reuptake transporter

Increases synaptic serotonin levels
High Selectivity

Minimal activity at other neurotransmitter systems

Reduced side effect profile
S-Enantiomer Activity

Active S-enantiomer of citalopram with enhanced potency

Superior therapeutic index
Mood Enhancement

Modulates serotonergic neurotransmission for antidepressant effect

Proven efficacy in depression and anxiety

Regulatory Compliance & Documentation

Comprehensive regulatory compliance ensures CNS pharmaceutical manufacturing access with complete documentation packages supporting international standards and SSRI antidepressant development.

USP Standards

United States Pharmacopeia CNS drug specifications

EP Monograph

European Pharmacopoeia specifications for SSRI agents

CNS GMP

Specialized GMP for CNS drug manufacturing

ICH Guidelines

International CNS drug development regulatory compliance

CNS DMF

Drug Master File for CNS applications

Safety Documentation

Comprehensive CNS safety and pharmacovigilance documentation

Technical Support & Value-Added Services

DRAVYOM's CNS pharmaceutical team provides comprehensive formulation support, stability testing, and regulatory services for Escitalopram Oxalate CNS applications.

CNS Formulation
  • SSRI formulation optimization
  • Bioavailability enhancement
  • Tablet and solution development
  • Custom CNS development
Analytical Services
  • API purity and potency analysis
  • CNS impurity profiling
  • Enantiomeric purity testing
  • Method validation support
Regulatory Support
  • CNS regulatory filing
  • SSRI DMF preparation
  • International compliance guidance
  • CNS pharmacovigilance
Supply Solutions
  • CNS pharmaceutical supply chain
  • Custom packaging solutions
  • Global distribution network
  • Emergency CNS supply

Environmental Impact & Sustainability

Our Escitalopram Oxalate production emphasizes environmental responsibility through sustainable CNS pharmaceutical manufacturing practices, waste minimization, and comprehensive environmental impact management.

Green Chemistry

Environmentally friendly CNS synthesis and processing methods

Water Conservation

Advanced water treatment and recycling systems

Clean Production

Energy-efficient CNS pharmaceutical manufacturing processes

Waste Reduction

Comprehensive CNS pharmaceutical waste management protocols

ISO 14001

Environmental management system certified production

Sustainable Sourcing

Responsible procurement of CNS pharmaceutical raw materials

Manufacturing Excellence & Quality Control

DRAVYOM's CNS pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent Escitalopram Oxalate quality and therapeutic performance.

CNS GMP

Specialized CNS manufacturing in controlled environment

Multi-stage purification for CNS grade quality
Quality Testing

Comprehensive testing including assay, impurities, and enantiomeric purity

HPLC verification and CNS analysis
Quality Systems

ISO 9001:2015 quality management with CNS compliance

Continuous improvement and CNS validation
CNS Packaging

Pharmaceutical-grade containers with moisture protection

Stability protection and contamination prevention

Market Applications & Performance Data

Comprehensive CNS data demonstrating Escitalopram Oxalate effectiveness in depression and anxiety treatment with quantified performance metrics and clinical validation data.

CNS Formulations
Bioavailability: 80% oral bioavailability Stability: 3-year shelf life validated Compatibility: Excellent with tablet and solution excipients
Therapeutic Applications
Depression: Proven antidepressant efficacy Anxiety: Effective for generalized anxiety disorder Safety: Well-tolerated SSRI profile
Manufacturing Performance
Yield: 97% pharmaceutical grade recovery Purity: >99.5% CNS specification Consistency: 99.8% batch-to-batch reproducibility

DRAVYOM Competitive Advantages

CNS Excellence

Superior CNS pharmaceutical grade with proven SSRI therapeutic performance and regulatory compliance

Reliable Supply

Guaranteed CNS supply with strategic inventory management and specialized production scheduling

CNS Expertise

Dedicated CNS pharmaceutical development team with specialized SSRI formulation support

Regulatory Compliance

Complete CNS documentation with DMF support and international compliance

Global Standards

International CNS compliance with USP, EP, and ICH guidelines

Partnership Approach

Collaborative CNS relationships with specialized development services